Through large-scale genome-wide association studies, these 842 FMRP targets have been shown to be genetically associated with schizophrenia [161, 162], autism [166], major depressive disorder [167], and bipolar disorder [58]. This evidence concerns the gene FMR1 and schizophrenia.